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Background: A new twin-peg version of the Oxford knee was introduced in 2003. However, until now there has
been no information about its survivorship. The aim of this study was to determine the survivorship, and the
patients' perception of outcome over time.
Methods: A cohort of all patients treated from 2003 until 2009 using the twin-peg Oxford partial knee was
contacted. The main indication for treatment was anteromedial osteoarthritis (AMOA). The Oxford Knee Score
(OKS), American Knee Society Functional (AKS-F) score and satisfaction rate were obtained, and the time-to-
failure was used to perform a survival analysis.
Results: There were 249 patients treated, with 288 medial cemented implants. Of these, 248 patients with 287
implants could be contacted and implant survival or failure was veriﬁed. Their mean age was 67 years (range:
34–94). The mean follow-up time was 5.1 years (maximum: 9.2). The nine years cumulative implant survival
rate for all cases using revision for any reason to deﬁne failure was 98% (95% CI, 84 to 100). There were no
cases of femoral loosening. The mean OKS was 22 pre-operatively, 41 at two years, and 41 at ﬁnal review, at
which point 96% of patients were very or fairly pleased with the result.
Conclusion: The survivorship of the twin-peg knee was better than that of the single peg knee at our centre, and
appeared no worse than the results of the single peg knee at the originating centre. It can offer secure femoral
ﬁxation, sustained clinical beneﬁt and patient satisfaction.
Level of evidence: Level IV case-series.© 2015 Elsevier B.V. All rights reserved.1. Introduction
Surgeons who implant unicompartmental knee replacements face a
challenge to consistently achieve excellent long-term results in terms of
a full range of movement, freedom from pain and long-term survivor-
ship. Throughout the world there have beenmixed results with a varie-
ty of modes of failure [1,2]. Although there was no case of femoral and
only one case of tibial loosening in a series of 1000 cases of patients
treated using the Oxford knee at the originating centre [1], others
found loosening to be themost common cause of failure [3,4]. In a series
of 1165 operations carried out between 1996 and 2008, loosening
accounted for 40% of 89 revisions [3]. The National Joint Registry for
England, Wales and Northern Ireland Annual Report of 2013 reports
loosening to be the commonest single cause of failure of mobile bearing
unicompartmental knee replacements, responsible for 25% of all revi-
sions [4]. Early femoral loosening proved to be an issue in our practicehite),
net (J.H. Kuiper).
, Shrewsbury, SY3 9DP, United
e cemented twin-peg Oxfordas well, at a rate of three of 31 cases within three years [5] and one of
78 knees by two years [6]. For this reason, we were keen to use a
more securely ﬁxed version of the Oxford implant.
In 2003, the twin-pegOxford femoral componentwasmade available.
It had been primarily designed to allow over 165° of ﬂexion after
unicompartmental replacement. Whilst the natural human knee can ac-
commodate such ﬂexion in sitting and kneeling, the single peg Oxford
femoral component would only be in partial contact with the bearing at
such extremes of ﬂexion (Fig. 1). The resulting increased stresses and
edge contact could accelerate polyethylene wear. The new femoral com-
ponent incorporating the extra femoral peg increases the arc and can be
inserted in greater ﬂexion, thereby addingmore contact with the bearing
in deep ﬂexion. With the approval of our new procedure committee and
our patients' informed consent, we decided to discontinue the phase III
single peg Oxford partial knee in 2003 in favour of the twin-peg version
(Fig. 2). In 2012 we reported our clinical results of the ﬁrst 100 patients
who had all reached two years of follow-up, and showed a mean Oxford
Knee Score (OKS) of 41, a mean American Knee Society knee (AKS-K)
score of 93, a functional (AKS-F) score of 84 and a mean 130° range
of ﬂexion [7]. The radiological analysis at two years showed no evidence
of femoral loosening [7]. However, the clinical results and survivorship
of this implant beyond two years are not known.partial knee replacement survivorship: A cohort study, Knee (2015),
Fig. 1. Single peg Oxford knee on the left, twin peg version on the right.
2 S.H. White et al. / The Knee xxx (2015) xxx–xxxThe aim of the present study therefore is to report the longer-term
implant survivorship and clinical outcome of the cemented twin-peg
Oxford partial knee in a patient cohort which includes the original
group of 100 patients, treated between 2003 and 2005, plus those
treated since until the end of 2009.
2. Patients and methods
2.1. Patients and outcome measures
This study comprised all patients operated upon using the cemented
twin-peg Oxford partial knee (Biomet UK Ltd, Bridgend, UK) by the se-
nior author or under his direct supervision up to and including 2009. Pa-
tients had been selected for treatment if they had medial compartment
osteoarthritis, which in most cases meant anteromedial osteoarthritis
[8], but also included patientswhohad previous traumaor avascular ne-
crosis. In AMOA there should be full thickness cartilage loss on both
sides of the medial compartment with bone on bone contact. There
should also be preservation of full thickness cartilage in the lateral com-
partment. The medial collateral ligament should be functionally normal
as demonstrated by a correctable intra-articular varus deformity at 20°
of ﬂexion. The anterior cruciate ligament (ACL) should be normal as
inspected and probed at surgery. The presence of a chondral ulcer on
the inter-condylar margin of the lateral femoral condyle can be ignored
as well as the patient's age, weight, level of activity and the presence of
chondrocalcinosis. Patients were excluded if there was evidence of in-
ﬂammatory arthritis or if there was ﬁxed ﬂexion of the knee beyond
10°. Patientswith patellofemoral osteoarthritis, regardless of the degreeFig. 2. Lateral radiograph showing the cemented twin peg Oxford knee.
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was considered more beneﬁcial in terms of patellofemoral contact
stresses compared to the pathomechanics that is inevitable on sacriﬁc-
ing the anterior cruciate ligament when carrying out total knee
replacement.
All patients were followed up at two years with radiographs, clinical
examination, and recording of the Oxford Knee Score (OKS) and
American Knee Society Functional (AKS-F) score [9,10]. In addition,
the range of motion of each knee was recorded by a research physio-
therapist (SR). A satisfaction questionnaire and a form to record any
complications that had occurred during the ﬁrst two years were
completed.
All patients who were alive and had the implant in-situ at the two
years clinical follow-up were contacted again for ﬁnal review up to
the tenth year after surgery using a variety of techniques: post, phone
call and ultimately by contacting the GP. They were assessed using a
postal questionnaire which included the OKS, the AKS-F, the Tegner Ac-
tivity score [11], and a satisfaction questionnaire as used in Oxford [1].
The process of ﬁnal review was begun in March 2012 and the
database ﬁnalised in July 2013. The extended duration was because of
difﬁculties in some cases of contacting patients. For patients who were
non-contactable, including those who had died, information was
gathered from hospital notes and by contacting the general practitioner
to conﬁrm whether the knee had been revised or not.
The operative technique was as previously described [7].
2.2. Statistical analysis
A multilevel model with a random intercept was used to determine
the difference between OKS scores pre-operatively and two years
post-operatively and between OKS scores and AKS-F scores two-years
post-operatively and at the latest follow-up. The multilevel method
was used to properly account for scores obtained from patients with
bilateral implants. It also allowed including all patients with at least
one score to investigate changes in score over time.
Implant survival was determined using the life-table method and
Greenwood estimates of the 95% conﬁdence intervals [12]. The lower
conﬁdence limit took account of the effective sample size at each time
point. Implant failure was deﬁned as revision for any reason.
All statistical analyses were performed using R vs 3.0.2, using the
packages “survival” and “nlme”. All statistical tests were performed as
two-tailed tests, and a p-value below 0.05 was assumed to denote
statistical signiﬁcance.
3. Results
3.1. Patient demography
There were 288 medial cemented implants, inserted in 249 patients (Table 1). There
were 210 unilateral and 39 bilateral procedures. Only one bilateral casewas simultaneous,Table 1
Demographic details.
Characteristic n or mean (SD) Range
Number of patients 249
Female 121
Male 128
Number of implants 288
Unilateral 210
Bilateral 39
Staged 38
Simultaneous 1
Age at operation 67.0 (9.8) 34 to 94
Indications
AMOA 267
AMOA extended 11
AVN/OCD 4
Trauma 3
Others 3
partial knee replacement survivorship: A cohort study, Knee (2015),
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Fig. 3. Survival curve for unicondylar Oxford knee prosthesis. Dashed lines represent 95%
conﬁdence interval, taking into account number currently at risk.
3S.H. White et al. / The Knee xxx (2015) xxx–xxxthe rest were staged. The mean age of the patients at the time of operation was 67 years
(range: 34 to 94). There were roughly equal numbers of women (121; 48.6%) and men
(128; 51.4%; Table 1). All patients could be followed up, either directly or through their
GP, except one patient who had ﬂown in for the surgery from abroad. Therefore, the
follow-up rate of the study was 99.6%.
3.2. Indications for surgery
The procedurewas undertaken in 267 knees for AMOA and 21 knees for other indica-
tions (Table 1). Eleven patients had extended indications for AMOA, recorded at the time
of surgery. In these cases either the ACL was abnormal or there was more extensive dam-
age to other joint compartments, but the joint was still deemed suitable for the procedure.
In addition, four knees demonstrated avascular avascular necrosis (AVN) or
osteochondritis dissecans (OCD) and three knees medial compartment arthritis due to
previous trauma, and one patient had a previous high tibial osteotomy. Because of the
small numbers of patients with conditions other than AMOA these have been grouped to-
gether as “other indications”.
3.3. Follow-up period
The mean follow-up period was 5.1 years, with a minimum of 2.7 years (excluding
patients who died or whose implant failed) and a maximum of 9.2 years. For 74% of the
knees, the follow-up period was at least four years.
3.4. Revision and survival
Five patients (ﬁve cases) required a revision: two patients who had AMOA indications
and three patients who had another indication (Table 2). The commonest reason for
revision was progression of osteoarthritis to the lateral compartment (three cases). In
addition, two patients required a revision due to unexplained pain; one was revised to a
total knee replacement with improved outcome, while the other patient was revised
elsewhere and the outcome is unknown. All of the revisions were during the ﬁrst ﬁve
years after knee replacement.
There were no cases of dislocation of the bearing, no cases of femoral loosening, and
no deep infections either early or late. One patient had complications of iatrogenic,
completemedial collateral division during the tibial cut due tomisplacement of themedial
retractor. The ligament was repaired, but during a period in a varus cast the tibial plateau
fractured. The fracture went on to heal with conservative treatment and although the
patient was “very disappointed” it has not led to revision.
Thenine years cumulative implant survival rate for all cases using revision for any rea-
son as the deﬁnition of failure was 98% (95% CI, 84 to 100; Fig. 3 and Table 3). The nine
years cumulative implant survival for AMOA cases was 99% (95% CI, 89 to 100) and the
seven years cumulative implant survival for other indication cases was 82% (95% CI, 55
to 100; Fig .2). Patients whose knees were treated for AMOA had a signiﬁcantly better
survivorship than patients with other indications (Fig 4; log rank test, p b 0.001).
3.5. Clinical outcome
Themean values for the OKS were 22.1 pre-operatively, 40.8 at two years, and 41.0 at
ﬁnal review (Table 4). Female patients scored a mean of 3.6 points lower than male pa-
tients, a signiﬁcant difference (p=0.001 for all timepoints). Themean difference in scores
was 19.0 points (95% CI, 17.4 to 20.7) from pre-op to two-years follow-up and 0.22 points
(95% CI,−0.69 to 1.14) between two years and the latest follow-up, with no signiﬁcant
difference between the genders (Table 4). The mean AKS-F scores were 80.0 points at
two years and 76.7 at the latest follow-up for female patients, and 88.2 and 83.9 points,
respectively, for male patients with a signiﬁcant difference between the genders and a
signiﬁcant drop over time (Table 4). Female patients had a mean Tegner Acivity score of
2.0 and amean range ofmotion of 128°, whereasmale patients had amean Tegner Acivity
score of 2.8 and a mean range of motion of 131°, a signiﬁcant difference in both cases
(Table 4). A higher age at operation signiﬁcantly reduced the AKS-F and the Tegner Acivity
score, but did not inﬂuence the OKS (Table 4). The indication (AMOA versus other) did not
inﬂuence any of the scores (Table 4).
Atﬁnal review220 patients (255 knees) rated their satisfaction. Of these patients, 191
(87%; 223 knees) were very pleased, 20 (nine percent; 20 knees) were fairly pleased, ﬁve
(two percent, ﬁve knees) were not very pleased and ﬁve (two percent, seven knees) were
very disappointed. The sum of patients was 221 rather than 220 because one bilateral
patient rated one knee differently to the other.Table 2
Overview of revision cases.
Revision case Time to revision Indication
1 1.4 Trauma
2 1.9 AMOA
3 3.7 AMOA extended
4 4.4 AMOA extended
5 4.7 AMOA
Please cite this article as: White SH, et al, The cemented twin-peg Oxford
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This is the ﬁrst study reporting survival of the cemented twin-peg
Oxfordmedial unicompartmental knee replacement, showing a survival
rate of 98% at nine years. This rate is comparable with the results using
the single peg cemented implant from the originating centre reported
by Pandit [1] and an independent centre reported by Svärd [2,13]. This
outcome is better than our previous results using the cemented single
peg implant [5,6] and the nine years survival rate of 89% reported in
the National Joint Registry of England, Wales and Northern Ireland
(NJR) or survival rates fromother national joint registers [4,14]. The sur-
vival rate was highest when carried out for the patients who satisﬁed
the original recommended indications for the Oxford knee:
anteromedial osteoarthritis (AMOA) [8]. Therewere no cases of femoral
loosening. Female andmale patients had a similar improvement in clin-
ical outcome, but female patients had lower preoperative as well as
postoperative clinical scores and a lower postoperative range of motion.
At the latest review, 96% of patients were pleased with their knee
replacement.
According to the 2013 report of the NJR, the cumulative percentage
probability of revision of the Oxford unicompartmental knee replace-
ment is 11.5% at the same time point of nine years [4]. Although the
NJR does not distinguish between single-peg and twin-peg Oxford
knees, the twin-peg version has not been widely available until after
2009 suggestingmost of the Oxford knees recorded in theNJR are single
peg versions. This rate of failure is typical of unicompartmental devices,
with even higher failure rates recorded for the AMC/Uniglide (11.8%)
and Preservation (17.3%) devices [4]. The results for the twin-peg im-
plant described in the current study are therefore considerably better
than those from the NJR, but what is the reason for this? Whilst it is
our contention that the twin-peg has advantages over the single pegReason for revision Revision and outcome
Unexplained pain and instability TKR with improved outcome
Lateral and PF OA TKR but remained painful at 1 year
Lateral OA TKR with poor result at 2.5 years
Unexplained pain Unknown
Lateral OA TKR mild valgus laxity at 6 months
partial knee replacement survivorship: A cohort study, Knee (2015),
Table 3
Life table for all 288 implants.
Year n at start n withdrawn n at risk n revised Failure Success Survival (95% CI)
Alive Dead Lost to follow-up
0–1 288 0 0 1 287.5 0 0.0 1.0 100 (100 to 100)
1–2 287 0 6 0 284 2 0.007 0.993 99.3 (98.3 to 100)
2–3 279 2 1 0 277.5 0 0.0 1.0 99.3 (98.3 to 100)
3–4 276 58 3 0 245.5 1 0.004 0.996 98.9 (97.5 to 100)
4–5 214 58 2 0 184 2 0.011 0.989 97.8 (95.7 to 99.8)
5–6 152 52 5 0 123.5 0 0.0 1.0 97.8 (95.1 to 99.8)
6–7 95 44 3 0 71.5 0 0.0 1.0 97.8 (94.1 to 99.8)
7–8 48 38 1 0 28.5 0 0.0 1.0 97.8 (89.9 to 99.8)
8–9 9 7 0 0 5.5 0 0.0 1.0 97.8 (83.9 to 99.8)
9–10 2 2 0 0 1 0 0.0 1.0 97.8 (75.1 to 99.8)
4 S.H. White et al. / The Knee xxx (2015) xxx–xxxOxford knee as it is more securely ﬁxed, there may well have been im-
provements in our selection of patients and surgical technique since
the 1990s, both of which are known to be critical for the success of the
Oxford knee [14].
Even though the revision rate was higher in patients who did not
satisfy the strict criteria for AMOA, the survivors did not have poorer
clinical outcomes (OKS, AKS-F, Tegner). This is in keeping with the re-
sults from the originating centre where a subgroup of patients with
other indications also did well generally [1]. The number of patients in
each subgroup with “other indications” is too small to make speciﬁc
recommendations. Further work is needed, perhaps by combining the
data from several centres.
The physician-assessed AKS-F score fell a little from the two years
measurement to ﬁnal follow-up, which is what one would expect as
patients age. However, the patient-assessed Oxford Knee Score of
41 at two yearswasmaintained at follow-up, showing sustained beneﬁt
in the patients' eyes with no suggestion of deterioration of the knee it-
self with time. This too is in keepingwith the ﬁndings of the originating
centre with the single peg version, at least to the seven years point [1].
A poorer outcome for the Oxford knee at two years in female pa-
tients was noted in a previous study [7] and was again observed hereAMOA
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Fig. 4. Implant survival curves for AMOA and extended indication cases treated with
unicondylar Oxford knee prosthesis. Thick lines represent AMOA cases, thin lines other in-
dication cases. Thick and thin dashed lines represent 95% conﬁdence intervals for each
group, taking into account number currently at risk. The upper 95% conﬁdence limits of
the two groups overlap and form the top thick dashed line.
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from the NJR about knee replacements in general [4]. This does not
make the cemented twin-peg option unsuitable for female patients, be-
cause the beneﬁt in terms of an increase in OKS is similar in both groups,
with no signiﬁcant difference between them.Moreover, the clinical out-
come in this series for female patients is better than that described for
either gender in the NJR for total knee replacements. Anatomical differ-
ences between male and female distal femurs, leading to a poorer ﬁt of
knee implants in female patients, may explain the poorer outcome in
female patients [15]. However, attempts to address this poorer ﬁt by
providing gender-speciﬁc implants have failed to reduce the gender-
gap in outcomes, leading to questions on the importance of these
anatomical differences [15].
During the period of follow-up no cases of femoral loosening were
found. This is encouraging as in the pastwe have had issues of loosening
with the single peg version [5]. It is interesting that other
unicompartmental knee manufacturers also provide two peg femoral
components, for example the PFC Sigma partial knee (DePuy, Leeds,
UK) and the Uniglide unicompartmental meniscal knee replacement
(Corin, Cirencester, UK). The cementless version of the Oxford partial
knee also has this design feature. This would suggest that convergent
design is occurring, recognising the enhanced ﬁxation of a two peg com-
pared to a single peg femoral component for unicompartmental knee
replacement.
Patients were in general satisﬁed with the results of their knee
replacement in the long term, with 96% of patients very pleased or fairly
pleased with the result. Still, four percent of patients were not very
pleased or were very disappointed. Again, this is no worse than the re-
sults of the cemented phase III knee reported by Pandit [1] using exactly
the same methodology of questionnaire. The satisfaction rate in the
current study is better than after total knee replacement where the
ﬁgure is only 82% in the NJR and 81% in the Swedish registry [16,17]. It
is likely that the improved range ofmotion and preservation of the stabi-
lizing cruciate mechanism are factors which favour unicompartmental
knee replacements over total knee replacements. This is reﬂected
by the more normal gait at faster walking speeds of patients with
unicompartmental knees compared to those with total knee replace-
ments [18].
No cases of deep infectionwere found in this period,which is consis-
tent with the literature on unicompartmental devices being associated
with lower infection risk than total knee replacements. It is likely that
the lesser degree of dissection and operative trauma to the soft tissues
causes less bleeding and haematoma formation which could provide a
breeding ground for bacteria. Indeed, it is exceedingly rare for patients
to require a blood transfusion in our experience and that of others [14].
The main weakness of this study is the lack of a contemporaneous
control group of patients because we stopped using the single peg ver-
sion in 2003 as a result of our observation of loosening [5,6]. During the
last 10 years, asmentioned earlier,we havenodoubt gained a better un-
derstanding of technical factors during surgery which may well have
contributed to improved results. Another weakness is our lack of long-partial knee replacement survivorship: A cohort study, Knee (2015),
Table 4
Pre-operative, two-years postoperative and latest clinical outcomes for male and female patients.
Score Gender Score (mean, SD) Score difference
(mean, 95% CI)
Pre-op Two-years Latest Pre vs post Post vs latest
OKS Combined 22.1 (8.2) 40.8 (7.4) 41.0 (8.5) 19.0
(17.4 to 20.7)
0.22
(−0.69 to 1.14)Female 21.0 (7.5) 39.2 (7.4) 39.1 (9.7)
Male 23.7 (9.1) 42.4 (7.2) 42.9 (6.7)
AKS-F Combined 84.2 (18.7) 80.4 (20.2) −3.7
(−5.9 to1.5)Female – 80.0 (19.0) 76.7 (21.9)
Male 88.2 (17.5) 83.9 (17.9)
Tegner Combined 2.4 (1.3)
Female 2.0 (1.1)
Male 2.8 (1.4)
ROM Combined 129 (8.3)
Female 128 (9.0)
Male 131 (7.2)
All outcomeswere analysed using a linearmultilevelmodel,with patient, knee and time as level one, two and three variables (see text for details). Gender, indication and agewere used as
ﬁxed factors to analyse their signiﬁcance. Differences in scores and their 95%CIs are the values of theﬁxed regression coefﬁcient for the factor time. Gender signiﬁcantly inﬂuenced theOKS
(p=0.001), AKS-F score (p b 0.001), Tegner Activity score (p b 0.001) and ROM (p=0.006), but not themean difference in scores. Results for score differenceswere therefore combined
for the genders. Age at operation signiﬁcantly inﬂuenced the AKS-F (p b 0.001) and the Tegner Activity score (p b 0.001) score but not the OKS (p = 0.45) and ROM (p = 0.17). No sig-
niﬁcant inﬂuence of indication on any clinical outcome was found (p N 0.1 for all analyses).
5S.H. White et al. / The Knee xxx (2015) xxx–xxxterm follow-up radiographs although all patients were X-rayed at two
years after surgery and there was no loosening around the central peg
at that stage or on any subsequent radiographs carried out for any clin-
ical reason. A strength of this study is the very complete follow-up, with
only one patient whose outcome is unknown. Furthermore, the conclu-
sions drawn from the revision data are reinforced by data from the NJR
which shows our revision rate for unicondylar knees to be an
“underlier” with a standardised revision ratio of 0.36, below the lower
99.8% conﬁdence limit for the expected ratio at the time of writing
(4 Feb 2015).
5. Conclusion
The survival rate of the cemented twin-peg Oxford partial knee in
the current serieswas higher than that of the single peg knee at our cen-
tre, higher than the national results for the Oxford partial knee reported
by the National Joint Registry, which mainly represent outcomes of the
single-peg implant, and appeared noworse than the results of the single
peg knee in the hands of the originating centre. The twin-peg implant
can offer secure femoral ﬁxation, and a high degree of sustained clinical
beneﬁt and patient satisfaction.
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